MedElevator Войти в исследования
← Поиск публикаций

DOI 10.61882/ijkd.20.01.8912

Медицинская библиотека · Iranian journal of kidney diseases · 2026

Predictors of Kidney and Patient Survival in Monoclonal Gammopathy-Associated Kidney Disease: A Single-Center Cohort from Colombia.

Gomez Jimenez Sebastian, Cano Rodas Simon, Carvajal Quiroz Jose Nelson, Arias Restrepo Luis Fernando, Rodelo-Ceballos Joaquín Roberto

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Monoclonal gammopathies can induce various kidney disorders through the deposition of monoclonal immunoglobulin. Precise recognition and classification are essential for predicting outcomes and customizing treatment. However, data on prognostic factors in Hispanic and Latin American populations remain scarce. This study aimed to determine the predictors of kidney and patient survival in adults with biopsy-proven monoclonal gammopathy-associated kidney disease.

METHODS

We conducted a retrospective cohort involving 98 individuals with biopsy-confirmed disease evaluated between 2011 and 2022. Kidney and patient survival were estimated using Kaplan-Meier analysis, and differences across histopathologic subtypes were assessed with the log-rank test. Predictors of end-stage kidney disease (ESKD) and mortality were identified using univariate and multivariable Cox regression after verification of the proportional hazards' assumption.

RESULTS

Approximately one third of patients required kidney replacement therapy (KRT) at presentation. The need for KRT (hazard ratio [HR] 4.86, 95% confidence interval [CI] 2.01-11.79) and an estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m² (HR 4.02, 95% CI 1.38-11.71) independently predicted progression to ESKD. Amyloidosis (HR 2.38, 95% CI 1.22-4.86) and age > 60 years (HR 1.96, 95% CI 1.06-3.61) were associated with higher mortality. The median follow-up was 41 months (interquartile range 24-68); 31% progressed to ESKD and 46% died.

CONCLUSIONS

Severe kidney dysfunction and the need for replacement therapy at diagnosis are strong predictors of poor renal outcomes. Amyloidosis and older age significantly affect overall survival. Early recognition of high-risk patients and access to effective, clone-directed therapy are essential to improve prognosis in resource-limited settings.

Для цитирования: Gomez Jimenez Sebastian, Cano Rodas Simon, Carvajal Quiroz Jose Nelson, Arias Restrepo Luis Fernando, Rodelo-Ceballos Joaquín Roberto. Predictors of Kidney and Patient Survival in Monoclonal Gammopathy-Associated Kidney Disease: A Single-Center Cohort from Colombia.. Iranian journal of kidney diseases. 2026. DOI: 10.61882/ijkd.20.01.8912.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.